Denali Therapeutics (DNLI) Interest Coverage Ratio (2017 - 2026)
Denali Therapeutics' (DNLI) quarterly Interest Coverage Ratio came in at 242.68 in Q1 2026, down 383.43% year-on-year from 85.62 in Q1 2025, and down 426.47% on a QoQ basis from 46.1 in Q4 2025.
Denali Therapeutics (DNLI) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Denali Therapeutics (DNLI) has 10 years of Interest Coverage Ratio data on file, last reported at 242.68 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 383.43% year-over-year to 242.68 in Q1 2026; TTM through Mar 2026 was 966.64, a 2062.16% decrease from a year earlier, with the FY2025 full-year figure at 39.36, down 3838.54% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 242.68, down from 46.1 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for DNLI reached as high as 61.7 in Q2 2023 and fell as low as 242.68 in Q1 2026.
- Historically, Interest Coverage Ratio has averaged 43.88 across 5 years, with a median of 40.85 in 2024.
- Across the five-year window, Interest Coverage Ratio soared 368.85% in 2023 and sank 383.43% in 2026, its largest moves.
- Year by year, Interest Coverage Ratio stood at 35.16 in 2022, then plunged by 34.99% to 47.47 in 2023, then advanced by 5.18% to 45.01 in 2024, then slipped by 2.42% to 46.1 in 2025, then sank by 426.47% to 242.68 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 242.68 in Q1 2026, 46.1 in Q4 2025, and 46.12 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Denali Therapeutics | 4.37 Bn | 4.37 Bn | - | -242.68 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -242.68 |
| Dec 31, 2025 | -46.10 |
| Sep 30, 2025 | -46.12 |
| Jun 30, 2025 | -2.81 |
| Mar 31, 2025 | -50.20 |
| Dec 31, 2024 | -45.01 |
| Sep 30, 2024 | -42.70 |
| Jun 30, 2024 | -40.85 |
| Mar 31, 2024 | -42.15 |
| Dec 31, 2023 | -47.47 |
| Sep 30, 2023 | -40.74 |
| Jun 30, 2023 | 61.70 |
| Mar 31, 2023 | -40.33 |
| Dec 31, 2022 | -35.16 |
| Sep 30, 2022 | -37.08 |
| Jun 30, 2022 | -22.95 |
| Mar 31, 2022 | -25.40 |
| Dec 31, 2021 | -29.45 |
| Sep 30, 2021 | -32.69 |
| Jun 30, 2021 | -24.12 |